A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Mar 2016
At a glance
- Drugs MT 8554 (Primary) ; Rosuvastatin; Simvastatin
- Indications Neurological disorders
- Focus Pharmacokinetics
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 23 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 16 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 15 Feb 2016 New trial record